• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Infect Dis . SARS-CoV-2 seroprevalence survey among 17,971 healthcare and administrative personnel at hospitals, pre-hospital services, and spe

tetano

Editor, Senior Moderator
Clin Infect Dis


. 2020 Oct 3;ciaa1471.
doi: 10.1093/cid/ciaa1471. Online ahead of print.
SARS-CoV-2 seroprevalence survey among 17,971 healthcare and administrative personnel at hospitals, pre-hospital services, and specialist practitioners in the Central Denmark Region


Sanne Jespersen[SUP] 1 [/SUP], Susan Mikkelsen[SUP] 2 [/SUP], Thomas Greve[SUP] 3 [/SUP], Kathrine Agerg?rd Kaspersen[SUP] 2 4 [/SUP], Martin Tolstrup[SUP] 1 [/SUP], Jens Kj?rgaard Boldsen[SUP] 2 4 [/SUP], Jacob Dvinge Redder[SUP] 5 [/SUP], Kent Nielsen[SUP] 6 [/SUP], Anders M?nsted Abildgaard[SUP] 7 [/SUP], Henrik Albert Kolstad[SUP] 8 [/SUP], Lars ?stergaard[SUP] 1 [/SUP], Marianne Kragh Thomsen[SUP] 3 [/SUP], Holger Jon M?ller[SUP] 7 [/SUP], Christian Erikstrup[SUP] 2 9 [/SUP]



Affiliations

Abstract

Background: The objective of this study was to perform a seroprevalence survey on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among Danish healthcare workers to identify high risk groups.
Methods: All healthcare workers and administrative personnel at the seven hospitals, pre-hospital services and specialist practitioner clinics in the Central Denmark Region were invited to be tested by a commercial SARS-CoV-2 total antibody enzyme-linked immunosorbent assay (ELISA, Wantai Biological Pharmacy Enterprise Co., Ltd., Beijing, China).
Results: A total of 25,950 participants were invited. Of these, 17,971 had samples available for SARS-CoV-2 antibody testing. After adjustment for assay sensitivity and specificity, the overall seroprevalence was 3.4% (CI: 2.5%-3.8%). The seroprevalence was higher in the western part of the region than in the eastern part (11.9% vs 1.2%, difference: 10.7 percentage points, CI: 9.5-12.2). In the high prevalence area, the emergency departments had the highest seroprevalence (29.7%), while departments without patients or with limited patient contact had the lowest seroprevalence (2.2%). Among the total 668 seropositive participants, 433 (64.8%) had previously been tested for SARS-CoV-2 RNA, and 50.0% had a positive RT-PCR result.
Conclusions: We found large differences in the prevalence of SARS-CoV-2 antibodies in staff working in the healthcare sector within a small geographical area of Denmark. Half of all seropositive staff had been tested positive by PCR prior to this survey. This study raises awareness of precautions which should be taken to avoid in-hospital transmission. Regular testing of healthcare workers for SARS-CoV-2 should be considered to identify areas with increased transmission.

Keywords: COVID-19; SARS-CoV-2; antibody; healthcare workers; serology.
 
Back
Top Bottom